Cannabinoids are a group of organic chemical compounds that are found in the cannabis plant. They are responsible for providing medicinal benefits such as pain relief, reducing inflammation, and treating various conditions like cancer, seizures, and Parkinson’s disease. Cannabinoids work by mimicking the natural endocannabinoids produced by the human body and binding to the same receptors located throughout the brain and body. This ability allows cannabinoids to communicate with the body in the same way that it communicates with itself, making it an ideal medicine for humans.
CBG, or cannabigerol, is a non-psychoactive cannabinoid that is found in low concentrations in most strains of cannabis. CBG is thought to have a wide range of potential medical benefits, including reducing inflammation, pain relief, and even fighting cancer cells. CBG has also been shown to have antibacterial properties and may be effective against conditions such as glaucoma.
CBC, or cannabichromene, is another non-psychoactive cannabinoid that is found in low concentrations in most strains of cannabis. It has been shown to have potential anti-inflammatory and pain-relieving effects. CBC may also have the potential to fight cancer cells and promote brain cell growth.
THCV, or tetrahydrocannabivarin, is a cannabinoid that is found in smaller amounts in most strains of cannabis. THCV has been shown to have potential appetite-suppressing effects, making it a potential treatment for obesity and diabetes. It may also have potential in treating anxiety and may have anticonvulsant properties.
THCA, or tetrahydrocannabinolic acid, is a cannabinoid that is found in raw, unheated cannabis. THCA is converted to THC when it is exposed to heat or sunlight, which is the compound that produces the psychoactive effects associated with cannabis use. THCA is thought to have potential in treating conditions such as inflammation, nausea, and vomiting.
CBN, or cannabinol, is a cannabinoid that is produced when THC is exposed to oxygen and degrades over time. CBN is thought to have potential in treating conditions such as insomnia and pain relief.
Delta 9 THC, or tetrahydrocannabinol, is the cannabinoid that is responsible for the psychoactive effects of cannabis. THC is the most well-known cannabinoid and has been shown to have potential in treating conditions such as chronic pain, nausea, and vomiting. It may also have potential in treating conditions such as glaucoma and multiple sclerosis.
CBDV, or cannabidivarin, is a non-psychoactive cannabinoid that is found in small amounts in most strains of cannabis. CBDV has been shown to have potential in treating conditions such as epilepsy and seizures. It may also have potential in treating conditions such as anxiety and inflammation.
CBD, or cannabidiol, is a non-psychoactive cannabinoid that is found in most strains of cannabis. CBD has been shown to have potential in treating conditions such as anxiety, depression, and chronic pain. It may also have potential in treating conditions such as epilepsy and Parkinson's disease. CBD has gained popularity in recent years due to its lack of psychoactive effects and potential therapeutic benefits.
Kowalczuk, Anna, et al. "Tetrahydrocannabivarin (THCV) Protects Adipose-Derived Mesenchymal Stem Cells (ASC) against Endoplasmic Reticulum Stress Development and Reduces Inflammation during Adipogenesis." Int J Mol Sci, vol. 24, no. 8, Apr. 2023, pp. 7120, doi:10.3390/ijms24087120, PMCID: PMC10138341.
Kim, Juyong, et al. "The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model." Int J Mol Sci, vol. 24, no. 7, Apr. 2023, pp. 6827, doi:10.3390/ijms24076827, PMCID: PMC10095267.